RNAseq data in the current study revealed that G0S2 regulates pathways involved in fatty acid metabolism in CML, which was confirmed by LC/MS‐based lipidomics analyses (Figure 7). This evidence concerns the gene G0S2 and chronic myelogenous leukemia, BCR-ABL1 positive.